Amarin Corp Plc (AMRN)

[HDGabor]

R-

how is ur feeling on the case so far and do you feel like the entry of the slide help prove intent to comment inducement and non obviousness?

Coming "soon" …

Abstract

I will focus on infringement, since I see obviousness as the easier (easy) part. Meanwhile generics could refer to small studies, small pieces these are - maximum - good to raise questions, to establish theory but these are not (are far away from) a “clear-and-convincing-evidence(s)”.

Best,
G

ps.:

with the rest of the world market we should still have peak revenue of over 2billion I would think. Which should still make it over 10 dollars stock. Do you really think 2 could be the value or is this u being funny?

The $"2" meaning was not the exact value … I did not make any projection about the pps (or fair value of Amarin / Vascepa) because we - nor me nor anybody else on this board - has all, necessary information (e.g. price by country in the EU … everywhere in the world; what will be the governmental subsidy in the EU; etc.) … it is big and complex. Just as an example (based on couldbebetter's post)

I believe that Europe could be 3 million patients and at $2000 a year would mean $6 billion a year in peak revenues making Europe worth $24 billion.

Let's assume "3 million patients and at $2000 a year" is correct … it is $6 billion a year in peak revenues …. AND (based on 25% royalty) Amarin's revenue is $1.5 billion